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Abstract
Background: Baroreﬂex dysfunction is a common feature of established cardiometabolic diseases that are most frequently
associated with the development of critical illness. Laboratory models show that baroreﬂex dysfunction impairs cardiac
contractility and cardiovascular performance, thereby increasing the risk of morbidity after trauma and sepsis. We
hypothesized that baroreﬂex dysfunction contributes to excess postoperativemorbidity aftermajor surgery as a consequence of
the inability to achieve adequate perioperative tissue oxygen delivery.
Methods: In a randomized controlled trial of goal-directed haemodynamic therapy (GDT) in higher-risk surgical patients,
baroreﬂex function was assessed using the spontaneous baroreﬂex sensitivity (BRS) method via an arterial line placed before
surgery, using a validated sequencemethod technique (one beat lag). The BRS was calculated during the 6 h postoperative GDT
intervention. Analyses of BRS were done by investigators blinded to clinical outcomes. The primary outcome was the
association between postoperative baroreﬂex dysfunction (BRS <6mmHg s−1, a negative prognostic threshold in cardiovascular
pathology) and early postoperativemorbidity. The relationship betweenbaroreﬂex dysfunctionandpostoperative attainmentof
preoperative indexed oxygen delivery was also assessed.
Results: Patients with postoperative baroreﬂex dysfunction were more likely to sustain infectious {relative risk (RR) 1.75 [95%
conﬁdence interval (CI): 1.07–2.85], P=0.02} and cardiovascular morbidity [RR 2.39 (95% CI: 1.22–4.71), P=0.008]. Prolonged hospital stay
wasmore likely inpatientswithbaroreﬂexdysfunction [unadjustedhazard ratio1.62 (95%CI: 1.14–2.32), log-rankP=0.004]. Postoperative
O2 delivery was 36% (95% CI: 7–65) lower in patients with baroreﬂex dysfunction in those not randomly assigned to GDT (P=0.02).
Conclusions: Baroreﬂex dysfunction is associated with excess morbidity, impaired cardiovascular performance, and delayed
hospital discharge, suggesting a mechanistic role for autonomic dysfunction in determining perioperative outcome.
Clinical trial registration: ISCRTN76894700.
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Established cardiometabolic disease, including heart failure and
diabetes mellitus, is strongly associated with increased risk of
perioperative morbidity. Autonomic dysfunction is frequently
subclinical and a feature of preoperative co-morbidities com-
monly associated with excess postoperative morbidity. Barore-
ﬂex autonomic dysfunction is an independent predictor of
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morbidity and mortality during critical illness.1 2 Several studies
have found that baroreﬂex sensitivity values <6 ms mmHg−1 are
associated with poorer outcomes.3–7 In part, this may reﬂect di-
minished parasympathetic (vagal) activity associatedwith baror-
eﬂex dysfunction.8 Laboratory and clinical epidemiological data
show that augmented vagal activity limits inﬂammation and
organ injury, including cardiovascular morbidity and mortality.9 10
In addition, we have shown in experimentalmodels that baroreﬂex
dysfunction promotes cardiac oxidative stress, thereby reducing
inotropic reserve and impairing cardiac function.11 Our transla-
tional laboratory studies have also suggested a mechanistic link
between parasympathetic dysfunction, impaired cardiac con-
tractility, and excess postoperative morbidity.11
As part of a randomized controlled trial exploring whether
postoperative morbidity might be reduced by ensuring that indi-
vidualized preoperative oxygen delivery was maintained,12 we
prospectively tested the hypothesis that baroreﬂex dysfunction
plays a role in the development of postoperative morbidity. We
postulated, on the basis of our laboratory and complementary
translational clinical ﬁndings,11 that baroreﬂex dysfunction con-
tributes to impaired perioperative cardiac performance, thereby
preventing postoperative achievement of preoperative oxygen
delivery, which we have shown is associated with excess
complications.
Methods
We previously conducted a multicentre, randomized, double-
blinded trial (trial registration: ISRCTN76894700) at four hospitals
in the UK.12 A prespeciﬁed analysis plan was published before
trial completion at www.ucl.ac.uk/anaesthesia/trials. Adult pa-
tients undergoing major elective surgery expected to last for at
least 2 h were eligible for recruitment provided they satisﬁed
the following high-risk criteria: (i) ASA physical status ≥III;
(ii) surgical procedures with an estimated or documented risk
of postoperative morbidity (as deﬁned by the PostOperative Mor-
bidity Survey) exceeding 50%; and (iii) modiﬁed Revised Cardiac
Risk Score ≥3,13 as deﬁned by age ≥70 yr, a history of cardiovas-
cular disease (myocardial infarction, coronary artery disease,
cerebrovascular accident, ECG evidence for established cardiac
pathology), cardiac failure, poor exercise capacity (anaerobic
threshold <11ml kgmin−1 as assessed by cardiopulmonary exer-
cise testing), renal impairment (serum creatinine ≥130 µmol l−1),
or diabetes mellitus. Intraoperative management was under-
taken by consultant anaesthetists, according to their usual prac-
tice. Patients were randomly assigned to either postoperative
goal-directed haemodynamic therapy (GDT) aimed at restoring
or preserving each patient’s individualized preoperative oxygen
delivery or protocolized care in a 1:1 ratio, stratiﬁed by opera-
tion type (STATA software). Central random allocation was
undertaken, with assignments concealed by envelope. Patients,
attending physicians, and critical care staff were blinded to the
patients’ treatment assignments. Apart from the trial statistician
and the data-monitoring committee, all treating physicians and
other investigators remained blinded to the trial results until fol-
low-up was completed.
Procedures
A radial arterial line was inserted before surgery to permit
calibrated cardiac output monitoring (LiDCOPlus; LiDCO Ltd,
London, UK).14 Haemodynamic data were recorded during sur-
gery and available for use by operating room staff. The interven-
tion period commenced once the patient reached the critical care
environment after surgeryand continued for 6 h. Haemodynamic
management in both randomization arms (i.e. GDT- and protoco-
lized control group-allocated patients) weremanaged exclusively
by research staff during the postoperative study period. Before
the intervention, in all patients, the LiDCO lithium-based sensor
was recalibrated to ensure accurate measurement of cardiac out-
put. Oxygenation (peripheral oxygen saturation ≥94%), haemo-
globin (>80 g l−1), core temperature (≥36°C), heart rate (<100
beats min−1), and mean arterial pressure (60–90 mm Hg), main-
tained using an α1-adrenoceptor agonist as required, were proto-
colized standard-of-care measures. Crystalloid ﬂuid (compound
sodium lactate) was administered at 1ml kg−1 h−1, with addition-
al ﬂuid administered according to protocol. Postoperative anal-
gesia was provided by thoracic epidural or patient-controlled
opiate analgesia. The goal-directed therapy intervention group
patients received i.v. ﬂuid and inotropic therapy according to
an algorithm (Supplementary data, Fig. S1) targeting each pa-
tient’s individualized preoperative oxygen delivery value. If the
preoperative oxygen delivery target was not met after the ﬁrst
hour of stroke volume optimization using gelatine colloid, an
i.v. infusion of dobutamine (1–20 μg kg min−1 via central venous
catheter) was commenced but strictly limited by heart rate para-
meters (<100 beats min−1, ≤25% from baseline heart rate at the
start of the intervention period, or both). A syringe with saline
or dobutamine, unidentiﬁable to all staff other than research per-
sonnel, was connected via extension tubing to the central venous
catheter of all patients. Cardiac output monitoring was not used
in the protocolized standard-of-care group, but all variables were
recorded. Calculation of oxygen delivery valueswas delayed until
the end of the trial in the control group. All other aspects of clin-
ical care were managed by intensive care unit clinicians, who
could alter any aspect of patient care provided the site principal,
chief investigator, or both were informed if haemodynamic
management during the study intervention period was involved
directly. Postoperative management adhered to enhanced re-
covery hospital protocols. Antibiotic use beyond prophylactic ad-
ministration (i.e. >24 h after surgery)was adeviation fromnormal
postoperative care.
Determination of baroreﬂex sensitivity
Spontaneous baroreﬂex sensitivity (BRS) was measured in surgi-
cal patients from the intra-arterial pressure recording15 (Fig. 1)
obtained immediately before surgery and for 6 h after surgery
using a validated sequence method technique (one beat lag).16
Baroreﬂex events across three or more consecutive beats were
identiﬁed where the systolic blood pressure and pulse interval
changed in tandem and were highly correlated (r>0.85). Sequen-
tial changes in systolic pressures that occurred with directionally
opposite changes in pulse interval were excluded from analysis,
Editor’s key points
• Autonomic dysfunction is associated with baroreﬂex im-
pairment or failure.
• This study found that baroreﬂex impairment was
associated with tissue ischaemia and postoperative
complications.
• Autonomic dysfunction thus seems to contribute to post-
operative morbidity.
• Interventions that restore or protect baroreﬂex function
may improve outcome.
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as they do not represent physiological baroreﬂex responses.
The slope of the linear regression line of pulse interval against
systolic blood pressure provided the BRS of each event in inmilli-
seconds per millimetre of mercury. Preoperative BRS was deter-
mined as the median slope value of all detected events. Median
BRS values ≤6mmHg s−1 for each hour of the postoperative period
were deﬁned as abnormal (baroreﬂex dysfunction), because BRS
values ≤6 ms mm Hg−1 have been consistently associated with
negative outcomes in preceding population-based studies3 5 17–20
We also assessed the incidence of markedly depressed baroreﬂex
sensitivity (≤3 ms mm Hg−1), which has previously identiﬁed pa-
tients at the most extreme risk of death after myocardial infarc-
tion.5 21 To avoid bias, all baroreﬂex analyses were undertaken by
investigators blinded to clinical outcomes.
Clinical outcomes
Morbidity was collected prospectively by assessors blinded to
the intervention and BRS data using the PostOperative Morbidity
Survey, which assesses all-cause morbidity throughout the pre-
ceding 24 h period.22 Failure to recover normally during the post-
operative periodwas deﬁned using the Clavien–Dindo scale, with
≥grade 2 complications representing clinically important devia-
tions from projected postoperative recovery.23 Thus, infectious
morbidity was deﬁned by microbiological conﬁrmation, a devi-
ation from normal postoperative care requiring antibiotic use be-
yond local, standardized prophylactic antibiotic therapy (i.e.
beyons 24 h after surgery), or both. The primary end point was
all-cause morbidity (Clavien–Dindo ≥grade 2 complications) on
postoperative day 2. Secondary outcomes were infectious mor-
bidity on postoperative day 2, mean postoperative oxygen deliv-
ery (expressed as a percentage of each patient’s preoperative
oxygen delivery target), and length of hospital stay (adjusting
for hospital deaths).
Statistical methods
Power analysiswas based on the results of the POM-O trial, which
showed that ∼54% patients sustained signiﬁcant morbidity
(≥grade 2, Clavien–Dindo scale)23 by postoperative day 2.12 On
the basis of our previous work,11 we estimated that signiﬁcant
morbidity would be >1.5 times more likely to occur in patients
with baroreﬂex dysfunction, which occurs in ∼35% patients.
Thus, the sample size required for an α-value of 0.05 and 80%
power would be ≥119 patients. For continuous data, normality
of distribution was assessed and, where appropriate, analysed
with balanced-design  [taking into account BRS <6 or >6
ms mm Hg−1, time point (Supplementary data, Fig. S2), and
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Fig 1 Baroreﬂex analysis and hospital stay. () Schematic diagram showingmeasurement and calculation of baroreﬂex sensitivity (BRS). Using a validated sequence
method technique (one beat lag), a baroreﬂex event is deﬁned by three or more consecutive beats where the systolic blood pressure (SBP) and pulse interval (PI)
changed in tandem and are highly correlated (r>0.85). () The slope of the linear regression line of PI against SBP generates the BRS of each event in milliseconds
per millimetre of mercury. () Baroreﬂex sensitivity <6 ms mm Hg−1 was associated with prolonged hospital stay [hazard ratio:1.62 (95% conﬁdence interval: 1.14–
2.32); P=0.004; unadjusted log-rank analysis]. Inset plot highlights length of stay in patients with BRS <3 ms mm Hg−1.
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randomization arm]. Non-parametric data were analysed with
the Mann–Whitney U-test. Relative risk (RR) and 95% conﬁdence
interval (CI) were estimated. Length of hospital stay was esti-
mated using the Kaplan–Meier method and analysed using the
Cox proportional hazardmodel. Multivariate analysiswas under-
taken to establish whether there was a signiﬁcant relationship
between postoperative baroreﬂex dysfunction and perioperative
factors associated with outcome,modulation of arterial barore-
ﬂex regulation, or both, taking into account preoperative [abso-
lute preoperative BRS value, albumin, diabetes mellitus,
cardiovascular morbidity (incorporating history of ischaemic
heart disease, heart failure, atrial ﬁbrillation, stroke, and anaer-
obic threshold <11 ml kg min−1), sex, age, and type of surgery]
and intraoperative factors (blood transfusion, lactate at end of
the operation, epidural use, and duration of operation), using a
hierarchical, one-way forward switchingmodel.24 A full set of re-
ferences supporting the choice of these factors is supplied in Sup-
plementary data, Table S1. A similar multivariate analysis was
undertaken to explore the relationship between BRS and oxygen
delivery after surgery, again using a hierarchical, one-way for-
ward switching model.24 All reported P-values are two sided.
Statistical analyses were performed using NCSS 8 (Kaysville,
UT, USA). Median values (interquartile range) are presented, un-
less stated otherwise. Signiﬁcance was accepted at P≤0.05.
Results
Baroreﬂex dysfunction in higher-risk surgical patients
Baroreﬂex sensitivity was calculated throughout the whole
perioperative period in 122/204 PostOperative Morbidity–Oxygen
delivery (POM-O) trial patients (Supplementary data, Fig. S1).
Preoperative recordings spanned a median duration of 39 min
(IQR: 31–55), capturing a median of 162 spontaneous events
((IQR: 90–271). Postoperative recordings spanned the entire 6 h
intervention period in all patients, with a median event rate of
174 h−1. Baroreﬂex dysfunction, as deﬁned by BRS ≤6 ms mm
Hg−1, was present in 54 of 122 patients (44%); clinical characteris-
tics are shown inTable 1.We identiﬁed 13 patients (11%)with BRS
values <3 mm Hg s−1, a threshold associated with particularly
poor prognosis in other disease states.5 21 25
Patients with preoperative BRS <6mmHg s−1 weremore likely
to have postoperative BRS <6 mm Hg s−1 [RR 2.6 (95% CI: 1.6–4.1),
P=0.003]. Given that intraoperative management and surgery as-
sociated with speciﬁc anaesthetic interventions (e.g. hepatobili-
ary patients receiving epidural analgesia)26 are known to affect
baroreﬂex regulation, we also assessed which factors were asso-
ciated with higher BRS values at the end of the postoperative
intervention period. We performed a multivariable analysis
taking into account co-morbidities associated with autonomic
dysfunction (diabetes mellitus, cardiac disease) and intraopera-
tive management (Table 2). We found that preoperative BRS
(P=0.0002; Supplementary Data, Fig. S2) was the only periopera-
tive factor associated with postoperative BRS.
Perioperative cardiovascular performance
Postoperative achievement of the individualized oxygen delivery
target was associated with higher BRS and randomization to
goal-directed therapy, taking into account age, sex, BMI, type of
surgery, and diabetic and cardiovascular morbidity (Table 2).
During surgery, similar volumes of ﬂuid and requirement for
pressor (norepinephrine) support were observed in patients
with normal BRS and baroreﬂex dysfunction, irrespective of
which trial arm they were subsequently assigned to randomly
(Table 3). The proportion of patients with baroreﬂex dysfunction
was similar between studyarms (Table 3). Although patientswith
baroreﬂex dysfunction were more likely to receive packed red
cells during surgery, haemoglobin concentrations were similar
between groups by the end of surgery and before the haemo-
dynamic intervention. Baroreﬂex dysfunction was associated
with higher plasma lactate concentration, which persisted
throughout the postoperative intervention period. After surgery,
oxygen delivery was 39% (95% CI: 11–68; P=0.001) lower than the
preoperative target in patients with baroreﬂex dysfunction not
randomized to GDT (Table 3; Supplementary Data, Fig. S2).
Baroreﬂex dysfunction and postoperative outcome
Patients with baroreﬂex dysfunction sustained more episodes
of signiﬁcant (Clavien–Dindo grade ≥2) morbidity by post-
operative day 2 [RR: 1.68 (95% CI: 1.19–2.44), P=0.003]. Baroreﬂex
dysfunction was associated with more infectious [RR: 1.75 (95%
CI: 1.07–2.85), P=0.02] and cardiovascular morbidity [RR: 2.39
(95% CI: 1.22–4.71), P=0.008] by postoperative day 2 (Table 4).
Throughout the perioperative stay, fewer patients with normal
BRS sustained (≥grade 2) Clavien–Dindo-deﬁned morbidity [RR:
0.73 (95% CI: 0.58–0.92), P=0.009] Prolonged hospital stay was
more likely in patients with baroreﬂex dysfunction [unadjusted
hazard ratio: 1.62 (95% CI: 1.14–2.32), log-rank P=0.004; Fig. 1].
Cox regression analysis identiﬁed baroreﬂex dysfunction [RR:
0.54 (95% CI: 0.35–0.83)], achievement of preoperative oxygen
delivery target [RR: 0.65 (95% CI: 0.43–0.98)], and type of surgery
[RR: 0.41 (95% CI: 0.20–0.86)] as signiﬁcant predictors of pro-
longed hospital stay.
Table 1 Baseline characteristics for PostOperative Morbidity–
Oxygen delivery (POM-O) trial patients in whom baroreﬂex
sensitivity was calculated before and after surgery. Data are
presented as the mean () or n (%). aThe percentage of patients
per group within each surgical category or hospital. BRS,
baroreﬂex sensitivity
Characteristic BRS >6 ms mm
Hg−1 (n=68)
BRS <6 ms mm
Hg−1 (n=54)
Age (yr) 67 (8) 68 (8)
Male 38 (56) 34 (63)
BMI (kg m−2) 26.1 (4.1) 28.5 (5.5)
Haemoglobin (g l−1) 123 (14) 129 (19)
Albumin (g dl−1) 43 (4) 41 (5)
Malignancy [n (%)] 54 (79) 38 (70)
Creatinine >130 µmol l−1 2 (3) 5 (9)
Diabetes mellitus [n (%)] 14 (21) 14 (26)
History of cardiovascular
disease [n (%)]
47 (69) 42 (77)
Surgical procedurea [n (%)]
Upper gastrointestinal 14 (54) 12 (46)
Liver resection/
hepatobiliary
37 (65) 20 (35)
Lower gastrointestinal 11 (48) 12 (52)
Vascular 6 (38) 10 (62)
Hospitala
University College
London Hospital
24 21
Royal Free Hospital 36 19
Royal London Hospital 2 4
St George’s Hospital 6 10
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Discussion
Our data show that patients with baroreﬂex dysfunction under-
going electivemajor surgery sustainmoremorbid events (charac-
terized by cardiac and infectious complications) and experience
prolonged hospitalization. These data suggest, for the ﬁrst time,
that baroreﬂex autonomic dysfunction may contribute to the de-
velopment of postoperative morbidity. Baroreﬂex dysfunction
was not more prevalent in co-morbidities linked to autonomic
dysfunction such as diabetesmellitus. This is perhaps unsurpris-
ing given the emerging link between autonomic dysfunction and
a range of cardiometabolic pathologies,27 coupledwith the recog-
nition that cardiovascular and autonomic function are frequently
impaired in patients presenting for cancer surgery.28
Established cardiac dysfunction is strongly associated with
excess postoperative morbidity and mortality.29 Autonomic dys-
function is frequently observed in established cardiac failure,
characterized by upregulation of G-protein-coupled receptor
(GPCR) kinase-2, which inhibits procontractile signalling by
phosphorylating the β-adrenoreceptor and inducing β-arrestin
binding.30 31 Impaired baseline function and inotropic responses
in laboratory models of baroreﬂex autonomic dysfunction are
consistent with impaired common GPCR signalling pathways
underlying this defect.11 Cardiovascular compromise is likely to
contribute to the higher mortality observed in rats with barore-
ﬂex dysfunction after acute endotoxaemia.32 In our study,
patients with baroreﬂex dysfunction had a higher venous lactate
concentration at the end of the intraoperative period, suggesting
that tissue dysoxia might have developed in part as a conse-
quence of lower oxygen delivery. Infectious complications after
tissue trauma are likely to be exacerbated by reduced oxygen de-
livery and strongly linked to subsequent mortality.33 Post-
operative oxygen delivery was lower in patients with baroreﬂex
dysfunction not randomized to GDT, and failure to achieve pre-
operative oxygen delivery was associated with lower BRS during
the intervention period. Despite GDT, higher venous lactate con-
centrations persisted in patients with baroreﬂex dysfunction;
these patients were more likely to acquire early postoperative
morbidity, necessitating interventions that deviated from normal
surgical care. Our exploratoryanalysis of haemodynamic perform-
anceshowsthat sustainedbaroreﬂexdysfunction (i.e. preoperative
BRS <6 ms mm Hg−1 persisting into the postoperative period) oc-
curs regardless of haemodynamic management. These ﬁndings
mirror those of recent haemodynamic trials in sepsis, where tar-
geting many aspects of oxygen delivery that were broadly similar
to those pursued in the POM-O trial failed to improve outcome.
These data therefore providea new lineof enquiry that contributes
to the debate about why goal-directed haemodynamic manage-
ment in critical illness does not appear to beneﬁt patients with
established, early sepsis or systemic inﬂammation.34
Defects in baroreﬂex function may occur in afferent neurons
transmitting the information from baroreceptors, brainstem
Table 2 Baroreﬂex dysfunction and postoperative oxygen delivery. Multivariate analysis assessing perioperative factors associated with
postoperative BRS () and achievement of preoperative oxygen delivery target (). BRS, baroreﬂex sensitivity; DO2 I, indexed oxygen delivery;
GI, gastrointestinal
Independent variable Regression coefﬁcient β Standard error T-value P-value Reject H0 (α<0.05)
. Perioperative factors associated with postoperative BRS
Intercept 3.1844 4.6746 0.681 0.50 No
Preoperative
Age −0.0186 0.0373 −0.498 0.62 No
Sex −0.5929 0.6191 −0.958 0.34 No
BMI −0.0589 0.0622 −0.948 0.35 No
Preoperative albumin 0.1123 0.0664 1.693 0.09 No
Cardiac morbidity −0.4401 0.6562 −0.671 0.5 No
Diabetes mellitus −0.7982 0.7933 −1.006 0.32 No
Hepatobiliary surgery 1.4997 0.8567 1.751 0.08 No
Upper GI surgery −0.5455 0.9864 −0.553 0.58 No
Vascular surgery 1.7551 1.5509 1.132 0.26 No
Preoperative BRS 0.4745 0.1242 3.82 0.0002 Yes
Intraoperative
Duration of operation −0.0022 0.0033 −0.663 0.50 No
Epidural 1.3221 0.7236 1.827 0.07 No
Blood transfusion −1.211 0.7136 −1.697 0.09 No
Lactate, end operation −0.4192 0.2649 −1.582 0.11 No
Vasopressor −0.7537 0.7562 −0.997 0.32 No
Postoperative
Trial intervention −0.0871 0.5905 −0.147 0.88 No
. Factors positively associated with higher oxygen delivery (% of preoperative DO2 I value)
Intercept 76.5974 34.8664 2.197 0.03 Yes
Age 0.1571 0.4755 0.33 0.74 No
Postoperative BRS >6 ms mm Hg−1 16.8889 8.1576 2.07 0.04 Yes
Cardiac morbidity −4.7209 8.8376 −0.534 0.59 No
Diabetes mellitus −7.1517 9.4787 −0.755 0.45 No
Lactate, end operation 1.6747 3.1388 0.534 0.59 No
Goal-directed therapy 17.9531 7.7602 2.313 0.02 Yes
Surgery type 3.2863 9.2815 0.354 0.72 No
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neurons, or the parasympathetic efferent limb.35 Laboratory
models have demonstrated that loss of vagal parasympathetic
activity exacerbates systemic inﬂammation in several organs,
through immuno-neuromodulation of α7 nicotinic receptors on
tissue-resident macrophages.36 Furthermore, vagal denervation
promotes persistent inﬂammation through failure to regulate
resolution of inﬂammation.37 The triad of inﬂammation, oxida-
tive stress, and impaired baroreﬂex sensitivity is well recognized
in the chronic development of cardiometabolic disease.38 In con-
scious rats, loss of baroreﬂex function impedes attenuation of
peripheral ( joint) inﬂammation,mediated by sympathetic neural
drive.39 Thus, acute inﬂammation superimposed on a lack of es-
tablished baroreﬂex ‘reserve’ may further detrimentally impair
the neural anti-inﬂammatory armamentarium, which conse-
quently jeopardizes metabolic homeostasis.40
We found that established baroreﬂex dysfunction was asso-
ciated with a higher incidence of intraoperative blood transfusion.
This observation may be mechanistically linked, because haemo-
stasis is inﬂuenced by parasympathetic neural activity. In experi-
mental soft tissue injury, haemorrhage is reduced after vagal
nerve stimulation.41 Diminished efferent (parasympathetic) activ-
ity, which contributes to baroreﬂex dysfunction, is promoted by
inﬂammatorymediators, opiates, andanaesthetic agents.42 43 Fur-
ther loss of parasympathetic neural activity triggered by haemor-
rhage, reperfusion, and consequent inﬂammation during major
surgery may therefore be particularly detrimental.44
Table 3 Perioperative haemodynamics and ﬂuid therapy. Data are presented as the mean (), median (quartiles), or n (%). P-values refer to
two-way  comparing haemodynamic intervention × baroreﬂex type. *Comparisons between haemodynamic therapy groups.
†Signiﬁcant difference for interaction between haemodynamic intervention × baroreﬂex type. ‡Signiﬁcant difference between baroreﬂex
types (BRS >6 vs <6 ms mm Hg−1). All patients received 1 ml kg−1 h−1 Ringers lactate crystalloid solution after surgery. BRS, baroreﬂex
sensitivity; DO2 I, indexed oxygen delivery; Hb, haemoglobin
Parameter Control arm Goal-directed therapy P-value
BRS >6 ms mm Hg−1
(n=31)
BRS <6 ms mm Hg−1
(n=22)
BRS >6 ms mm Hg−1
(n=37)
BRS <6 ms mm Hg−1
(n=32)
Preoperative
Haemoglobin (g l−1) 126 (15) 132 (11) 121 (14) 126 (20) 0.71
Cardiac output (ml min−1) 6.1 (1.5) 6.8 (1.6) 5.9 (2.0) 6.2 (1.8) 0.62
DO2 I (ml min
−1 kg−1) 550 (157) 607 (140) 516 (166) 559 (171) 0.26
Intraoperative
Crystalloid (ml kg−1 h−1) 13.3 (8.2) 9.1 (2.9) 10.7 (4.9) 10.5 (5.7) 0.22
Colloid (ml kg−1 h−1) 2.4 (0–5.4) 2.3 (0.7–3.6) 1.8 (0–3.7) 1.6 (0–4.1) 0.68
Blood [n (%)] 2 (6) 8 (36)‡ 7 (19) 11 (34)‡ 0.02
Hb (g l−1), end of operation 105 (11) 108 (18) 103 (13) 110 (18) 0.31
Vasopressor [n (%)] 6 (19) 5 (23) 6 (16) 8 (25) 0.82
Lactate (mmol l−1) 1.6 (1.0) 2.9 (1.3)*‡ 2.0 (1.1) 2.3 (1.6)‡ 0.03‡; <0.01*
Cardiac output (ml min−1) 5.6 (2.5) 6.3 (3.1) 5.2 (2.3) 5.2 (1.4) 0.40
DO2 I (ml min kg
−1) 483 (197) 518 (255) 470 (223) 451 (147) 0.48
Postoperative
Colloid (ml kg−1 h−1) 1.8 (1.6) 2.0 (1.8) 3.0 (1.6)* 2.9 (2.1)* 0.005*
Blood [n (%)] 3 (10) 6 (27) 7 (19) 11 (34) 0.11
Dobutamine [n (%)] 0 0 13 (35)* 12 (38)* <0.001*
Lactate (mmol l−1) 1.4 (0.6) 2.1 (0.8)‡ 1.9 (1.6) 2.7 (1.8)‡ 0.003‡
Cardiac output (ml min−1) 6.1 (2.0) 6.0 (1.7) 6.8 (2.1)* 7.4 (2.1)* 0.006*
DO2 I (ml min
−1 kg−1) 497 (174) 431 (132)† 537 (164)* 599 (180)* <0.01*; 0.04†
Table 4Morbidity on postoperative day 2, stratiﬁed by postoperative baroreﬂex sensitivity. Data are represented as numberof patients (%) for
respective baroreﬂex sensitivity category. P-values were calculated using Fisher’s exact test. ARR, absolute risk reduction; CI, conﬁdence
interval; POMS, PostOperative Morbidity Survey
Morbidity Normal baroreﬂex sensitivity (n=68) Baroreﬂex dysfunction (n=54) ARR (%) (95% CI) P-value
Clavien–Dindo >grade 2 27 (40) 36 (67) 27 (10–44) 0.003
POMS-deﬁned morbidity
Pulmonary 56 (82) 45 (83) −1 (−12 to 14) 0.89
Infection 18 (26) 25 (46) 20 (3–37) 0.02
Renal 61 (90) 46 (85) −5 (−16 to 7) 0.45
Gastrointestinal 42 (62) 37 (69) 7 (−10 to 24) 0.44
Cardiovascular 10 (15) 19 (35) 21 (5–36) 0.008
Neurological 7 (10) 10 (19) 8 (−4 to 21) 0.19
Wound 2 (3) 3 (6) 3 (−5 to 10) 0.47
Haematological 7 (10) 7 (13) 3 (−9 to 14) 0.65
Pain 58 (85) 43 (80) −6 (−19 to 8) 0.41
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Masking of the serial BRS analyses to outcomes is a signiﬁcant
strength of this study. In-depth haemodynamic characterization
was also undertaken blinded to BRS data. Collecting the BRS data
serially as part of a randomized controlled trial offers a further
mechanistic insight into the role of autonomic dysfunction. Lim-
itations include the exclusion of patients because of unantici-
pated ineligibility for analysis (atrial ﬁbrillation, dysrhythmias),
suboptimal waveform characterization, and loss of data during
downloading because of hardware dysfunction. Our study com-
pares favourably with similar translational studies conducted
in ‘real-world’ clinical scenarios, where the acquisition and ana-
lysis of complex waveform data is typically associated with ∼30%
exclusion rates.45 46 There was no systematic pattern to patients
being excluded, other than the failure of one monitoring device
that ‘dumped’ the data setwhile saving to an external storage de-
vice. Exclusions occurred randomly throughout the study and
from all recruiting sites. Spontaneous baroreﬂex sensitivity is a
useful ‘real-world’ measure of baroreﬂex, but these data might
have been strengthened by complementary baroreﬂex assess-
ment, including the ramp technique, which requires using vaso-
active drugs serially.47 However, logistic and clinical restrictions
precluded this additional approach.
In summary, our ﬁndings suggest that baroreﬂex dysfunction
might contribute to the development of postoperativemorbidity.
These data present an alternativemechanistic paradigm through
which existing or novel pharmacological approaches may be ex-
plored in an effort to limit the excess morbidity and mortality
after signiﬁcant tissue trauma and systemic inﬂammation.
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